The Cancer Vaccines Market is expected to grow at a CAGR of 14% from 2020-2030
A vaccine is a biological
preparation that is introduced in human body in order to acquire immunity
against diseases. Cancer is a chronic disorder that leads to uncontrolled cell
growth & conquer other tissues in the body. Cancer vaccine is specially
designed to increase immunity in human body against cancer by creating
antibodies against them. These antibodies then recognize the cancer cells and
suppress its growth.
According to the report, the
high prevalence rate of cancer and growth in human papilloma virus (HPV)
infections are the major factors driving the market growth. Also, surge in
research & development activities owing to the growth in market investments
led to the launch of new vaccines. Furthermore, rising awareness among people
along with surge in vaccination as well as growth in government initiatives to
promote vaccination are also expected to gain traction. Moreover, development
in healthcare facilities supported by the government funding & high
investments for the development of new cancer vaccines is also expected to
amplify the market growth. Other factors such as huge product pipeline and
rising demand for cancer vaccines can change the market trends.
However, high cost of cancer
vaccines owing to the high R&D cost and stringent regulatory process for
approval is likely to inhibit the market growth. Moreover, rising demand for
therapeutic vaccines and increasing approval of new vaccines are expected to provide
numerous opportunities to the market players in the coming few years.
On the basis of technology, the
cancer vaccines market share is segmented into subunit vaccines, conjugate
vaccines, inactivated vaccines, live attenuated vaccines, and recombinant
vector vaccines. Recombinant vectors vaccine holds the major market share in
the cancer vaccine market and is expected to dominate the market throughout the
forecast period.
On the basis of treatment
method, the cancer vaccines market is categorised into preventive vaccine and
therapeutic vaccine. Preventive vaccine holds the major market share and is
expected to dominate the market growth.
On the basis of indication, the
cancer vaccine market is fragmented into prostate cancer, liver cancer,
cervical cancer, skin cancer, and others. Prostate cancer is expected to
develop significantly over the period of time and is likely to dominate the
market among all other indication types.
On the basis of end user, the
market is bifurcated into adult vaccines and paediatric vaccine. The adult
vaccines segment is likely to develop at a significant growth rate owing to
high prevalence rate in adults.
North America dominates the
cancer vaccine market in terms of market share & size over the forecast
period owing to the presence of developed healthcare facilities &
infrastructure and rising number of cancer patients. In addition, surge in
research & development activities along with increasing approvals for new
cancer vaccines are expected to contribute market growth. Europe accounts for
the second leading position in the cancer vaccines market in terms of market size.
Asia Pacific is expected to be the fastest developing region in the cancer
vaccines market, majorly driven by the high government funding for the
development of new vaccines. Moreover, rising prevalence of cancer and growth
in HPV infections are also expected to promote the market growth.
According to the report, some the key
players in the cancer vaccines market are CSL Limited, Pfizer Inc.,
Bristol-Myers Squibb, Astrazeneca Plc., Sanofi Pasteur, AduroBioTech Inc.,
Sanpower Group, Glaxosmithkline Plc., Merck & Co., Inc., AstellasPharma Inc.
Browse key
industry insights from the report, “Cancer Vaccines Market Size By Technology (Subunit Vaccines, Conjugate
Vaccines, Inactivated Vaccines, Live Attenuated Vaccines, and Recombinant
Vector Vaccines) By Treatment Method (Preventive Vaccine and Therapeutic
Vaccine), By Indication (Prostate Cancer, Liver Cancer, Cervical Cancer, Skin
Cancer, and Others), By End User (Adult Vaccines and Paediatric Vaccine)Regional
Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India,
Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, South
Africa, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, Competitive
Market Share & Forecast, 2020–2030” in detail along with the table
of contents:
Key Insights from the Cancer
Vaccines Market Report:
- Asia Pacific is the fastest
growing region in the Cancer Vaccines market owing to the rising
prevalence of cancer, growth in HPV infections and high government funding
for the development of new vaccine.
·
The prostate cancer segments dominates
the market in terms of indication and is expected to grow at a significant CAGR
to maintain the lead till 2030.
- Some of the major players in the market are CSL
Limited, Pfizer Inc., Bristol-Myers Squibb, Astrazeneca Plc., Sanofi
Pasteur, Aduro BioTech Inc., Sanpower Group, Glaxosmithkline Plc., Merck
& Co., Inc., Astellas Pharma Inc.
The report Cancer Vaccines market – segmented by technology, treatment
method, indication, end user and geography
Get a free sample on the Cancer Vaccines Market
reports
About Next Move Strategy Consulting
Next
Move Strategy Consulting is an independent and trusted third-platform market
intelligence provider, committed to deliver high quality, market research
reports that help multinational companies to triumph over their competitions
and increase industry footprint by capturing greater market share. Our research
model is a unique collaboration of primary research, secondary research, data
mining and data analytics.
We
have been servicing over 1000 customers globally that includes 90% of the
Fortune 500 companies over a decade. Our analysts are constantly tracking
various high growth markets and identifying hidden opportunities in each sector
or the industry. We provide one of the industry’s best quality syndicate as
well as custom research reports across 10 different industry verticals. We are
committed to deliver high quality research solutions in accordance to your
business needs. Our industry standard delivery solutions that ranges from the
pre consultation to after-sales services, provide an excellent client
experience and ensure right strategic decision making for businesses.
Comments
Post a Comment